# Drugs in R&D

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/drugs-in-r-and-d/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 1174-5886 |
| ISSNs | 1174-5886,1179-6901 |
| OpenAlex ID | https://openalex.org/S35266406 |
| Publisher | Adis, Springer Healthcare |

## Journal papers

- [The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis](https://scholariq.org/papers/the-benefits-and-risks-of-switching-from-fingolimod-to-siponimod-for-the/)
- [Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch](https://scholariq.org/papers/analysis-of-the-us-safety-data-for-edaravone-radicava-from-the-third-year-after/)
- [Safety of Mebendazole Use During Lactation: A Case Series Report](https://scholariq.org/papers/safety-of-mebendazole-use-during-lactation-a-case-series-report/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.